117 related articles for article (PubMed ID: 23045189)
1. Testosterone treatment improves metabolic syndrome-induced adipose tissue derangements.
Maneschi E; Morelli A; Filippi S; Cellai I; Comeglio P; Mazzanti B; Mello T; Calcagno A; Sarchielli E; Vignozzi L; Saad F; Vettor R; Vannelli GB; Maggi M
J Endocrinol; 2012 Dec; 215(3):347-62. PubMed ID: 23045189
[TBL] [Abstract][Full Text] [Related]
2. FXR activation normalizes insulin sensitivity in visceral preadipocytes of a rabbit model of MetS.
Maneschi E; Vignozzi L; Morelli A; Mello T; Filippi S; Cellai I; Comeglio P; Sarchielli E; Calcagno A; Mazzanti B; Vettor R; Vannelli GB; Adorini L; Maggi M
J Endocrinol; 2013; 218(2):215-31. PubMed ID: 23750014
[TBL] [Abstract][Full Text] [Related]
3. Testosterone and farnesoid X receptor agonist INT-747 counteract high fat diet-induced bladder alterations in a rabbit model of metabolic syndrome.
Morelli A; Comeglio P; Filippi S; Sarchielli E; Cellai I; Vignozzi L; Yehiely-Cohen R; Maneschi E; Gacci M; Carini M; Adorini L; Vannelli GB; Maggi M
J Steroid Biochem Mol Biol; 2012 Oct; 132(1-2):80-92. PubMed ID: 22406511
[TBL] [Abstract][Full Text] [Related]
4. Tadalafil reduces visceral adipose tissue accumulation by promoting preadipocytes differentiation towards a metabolically healthy phenotype: Studies in rabbits.
Maneschi E; Cellai I; Aversa A; Mello T; Filippi S; Comeglio P; Bani D; Guasti D; Sarchielli E; Salvatore G; Morelli A; Mazzanti B; Corcetto F; Corno C; Francomano D; Galli A; Vannelli GB; Lenzi A; Mannucci E; Maggi M; Vignozzi L
Mol Cell Endocrinol; 2016 Mar; 424():50-70. PubMed ID: 26805634
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of action of phosphodiesterase type 5 inhibition in metabolic syndrome-associated prostate alterations: an experimental study in the rabbit.
Morelli A; Comeglio P; Filippi S; Sarchielli E; Vignozzi L; Maneschi E; Cellai I; Gacci M; Lenzi A; Vannelli GB; Maggi M
Prostate; 2013 Mar; 73(4):428-41. PubMed ID: 22996758
[TBL] [Abstract][Full Text] [Related]
6. INT-767 prevents NASH and promotes visceral fat brown adipogenesis and mitochondrial function.
Comeglio P; Cellai I; Mello T; Filippi S; Maneschi E; Corcetto F; Corno C; Sarchielli E; Morelli A; Rapizzi E; Bani D; Guasti D; Vannelli GB; Galli A; Adorini L; Maggi M; Vignozzi L
J Endocrinol; 2018 Aug; 238(2):107-127. PubMed ID: 29945982
[TBL] [Abstract][Full Text] [Related]
7. Subcutaneous abdominal adipose tissue subcompartments: potential role in rosiglitazone effects.
Walker GE; Marzullo P; Verti B; Guzzaloni G; Maestrini S; Zurleni F; Liuzzi A; Di Blasio AM
Obesity (Silver Spring); 2008 Sep; 16(9):1983-91. PubMed ID: 19186324
[TBL] [Abstract][Full Text] [Related]
8. Testosterone partially ameliorates metabolic profile and erectile responsiveness to PDE5 inhibitors in an animal model of male metabolic syndrome.
Filippi S; Vignozzi L; Morelli A; Chavalmane AK; Sarchielli E; Fibbi B; Saad F; Sandner P; Ruggiano P; Vannelli GB; Mannucci E; Maggi M
J Sex Med; 2009 Dec; 6(12):3274-88. PubMed ID: 19732305
[TBL] [Abstract][Full Text] [Related]
9. Deep subcutaneous adipose tissue: a distinct abdominal adipose depot.
Walker GE; Verti B; Marzullo P; Savia G; Mencarelli M; Zurleni F; Liuzzi A; Di Blasio AM
Obesity (Silver Spring); 2007 Aug; 15(8):1933-43. PubMed ID: 17712110
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II stimulates and atrial natriuretic peptide inhibits human visceral adipocyte growth.
Sarzani R; Marcucci P; Salvi F; Bordicchia M; Espinosa E; Mucci L; Lorenzetti B; Minardi D; Muzzonigro G; Dessì-Fulgheri P; Rappelli A
Int J Obes (Lond); 2008 Feb; 32(2):259-67. PubMed ID: 17878892
[TBL] [Abstract][Full Text] [Related]
11. Excess fructose intake-induced hypertrophic visceral adipose tissue results from unbalanced precursor cell adipogenic signals.
Zubiría MG; Fariña JP; Moreno G; Gagliardino JJ; Spinedi E; Giovambattista A
FEBS J; 2013 Nov; 280(22):5864-74. PubMed ID: 23992485
[TBL] [Abstract][Full Text] [Related]
12. Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome.
Wajchenberg BL; Giannella-Neto D; da Silva ME; Santos RF
Horm Metab Res; 2002; 34(11-12):616-21. PubMed ID: 12660870
[TBL] [Abstract][Full Text] [Related]
13. Chinese herbal extracts (SK0506) as a potential candidate for the therapy of the metabolic syndrome.
Tan Y; Kamal MA; Wang ZZ; Xiao W; Seale JP; Qu X
Clin Sci (Lond); 2011 Apr; 120(7):297-305. PubMed ID: 20950275
[TBL] [Abstract][Full Text] [Related]
14. The Korean traditional medicine gyeongshingangjeehwan inhibits adipocyte hypertrophy and visceral adipose tissue accumulation by activating PPARalpha actions in rat white adipose tissues.
Shin SS; Jung YS; Yoon KH; Choi S; Hong Y; Park D; Lee H; Seo BI; Lee HY; Yoon M
J Ethnopharmacol; 2010 Jan; 127(1):47-54. PubMed ID: 19799979
[TBL] [Abstract][Full Text] [Related]
15. Testosterone protects from metabolic syndrome-associated prostate inflammation: an experimental study in rabbit.
Vignozzi L; Morelli A; Sarchielli E; Comeglio P; Filippi S; Cellai I; Maneschi E; Serni S; Gacci M; Carini M; Piccinni MP; Saad F; Adorini L; Vannelli GB; Maggi M
J Endocrinol; 2012 Jan; 212(1):71-84. PubMed ID: 22010203
[TBL] [Abstract][Full Text] [Related]
16. Selenium‑enriched exopolysaccharides produced by Enterobacter cloacae Z0206 alleviate adipose inflammation in diabetic KKAy mice through the AMPK/SirT1 pathway.
Zhou X; Wang F; Yang H; Chen J; Ren Y; Yuan Z; Wang X; Wang Y
Mol Med Rep; 2014 Feb; 9(2):683-8. PubMed ID: 24337047
[TBL] [Abstract][Full Text] [Related]
17. Lpin1 in human visceral and subcutaneous adipose tissue: similar levels but different associations with lipogenic and lipolytic genes.
Miranda M; Escoté X; Alcaide MJ; Solano E; Ceperuelo-Mallafré V; Hernández P; Wabitsch M; Vendrell J
Am J Physiol Endocrinol Metab; 2010 Aug; 299(2):E308-17. PubMed ID: 20530740
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic steatohepatitis as a novel player in metabolic syndrome-induced erectile dysfunction: an experimental study in the rabbit.
Vignozzi L; Filippi S; Comeglio P; Cellai I; Sarchielli E; Morelli A; Rastrelli G; Maneschi E; Galli A; Vannelli GB; Saad F; Mannucci E; Adorini L; Maggi M
Mol Cell Endocrinol; 2014 Mar; 384(1-2):143-54. PubMed ID: 24486698
[TBL] [Abstract][Full Text] [Related]
19. Obestatin regulates adipocyte function and protects against diet-induced insulin resistance and inflammation.
Granata R; Gallo D; Luque RM; Baragli A; Scarlatti F; Grande C; Gesmundo I; Córdoba-Chacón J; Bergandi L; Settanni F; Togliatto G; Volante M; Garetto S; Annunziata M; Chanclón B; Gargantini E; Rocchietto S; Matera L; Datta G; Morino M; Brizzi MF; Ong H; Camussi G; Castaño JP; Papotti M; Ghigo E
FASEB J; 2012 Aug; 26(8):3393-411. PubMed ID: 22601779
[TBL] [Abstract][Full Text] [Related]
20. Visceral obesity, impaired glucose tolerance, metabolic syndrome, and growth hormone therapy.
Attallah H; Friedlander AL; Hoffman AR
Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S62-7. PubMed ID: 16624603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
